Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Howard

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses|August 15, 2024
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses|March 9, 2025
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024Liliana Antunes, Madelyn Rojas-Castro, Marcos Lozano, et al.
Global Change Biology|March 1, 2020
Mangrove blue carbon stocks and dynamics are controlled by hydrogeomorphic settings and land-use changeSigit D Sasmito, Mériadec Sillanpää, Matthew A Hayes, et al.
Ambio|May 3, 2022
Integrating blue: How do we make nationally determined contributions work for both blue carbon and local coastal communities?Amrit Melissa Dencer-Brown, Robyn Shilland, Daniel Friess, et al.
Influenza and Other Respiratory Viruses|February 25, 2024
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital networkAngela M C Rose, Francisco Pozo, Iván Martínez-Baz, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 23, 2024
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses|August 15, 2024
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024Liliana Antunes, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses|March 9, 2025
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024Liliana Antunes, Madelyn Rojas-Castro, Marcos Lozano, et al.
Global Change Biology|March 1, 2020
Mangrove blue carbon stocks and dynamics are controlled by hydrogeomorphic settings and land-use changeSigit D Sasmito, Mériadec Sillanpää, Matthew A Hayes, et al.
Ambio|May 3, 2022
Integrating blue: How do we make nationally determined contributions work for both blue carbon and local coastal communities?Amrit Melissa Dencer-Brown, Robyn Shilland, Daniel Friess, et al.
Influenza and Other Respiratory Viruses|February 25, 2024
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital networkAngela M C Rose, Francisco Pozo, Iván Martínez-Baz, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 23, 2024
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Pageof 5